Some of the biggest names in chess are coming to Arlington this fall. On October 4, Esports Stadium Arlington will host Checkmate: USA vs. India, a first-of-its-kind chess event boasting world ...

D Gukesh faced criticism after a disappointing performance at the Paris Freestyle Grand Slam Tour. Despite his poor showing, he received strong support from the Indian chess community. Norwegian ...

Srinath Narayanan, one of India’s premier chess coaches, has come forward to defend the youngest and current World Champion D Gukesh after his poor run at the recently concluded Paris Freestyle Grand ...

Rushing to D Gukesh’s defence, Indian GM Srinath Narayanan had a brutal reply for the reigning World Champion's critics. The pressure has been mounting on D Gukesh after another poor Freestyle ...

Viswanathan Anand anticipates epic battles as Gukesh D prepares to face Magnus Carlsen at Norway Chess 2025. The tournament, running from May 26 to June 6 in Stavanger, features a strong lineup ...

The game has also gotten increasingly global, Cheng said, with around 85% of new user registrations coming from outside the U.S. The current World Champion, Gukesh Dommaraju, hails from India.

Samson, who scored 224 runs from seven matches at an average above 30 and a strike rate exceeding 140, played the first three matches only as a specialist batter and has since missed two matches ...

FMCG major Nestle India on Thursday reported a 6.5 per cent decline in its consolidated net profit to Rs 873.46 crore for the fourth quarter ended March 31, 2025. Its revenue from the sale of products ...

Matt Miller is an NFL draft analyst for ESPN, providing in-depth scouting on the nation's top pro prospects. A Missouri native, Matt joined ESPN in 2021 and also contributes to SportsCenter, NFL ...

Koneru Humpy finished joint-top along with Zhu Jiner at the FIDE Women's Grand Prix event in Pune to move to overall second place in the Grand Prix series. It is a significant result for Humpy as ...

Recently, Biocon Biologics had inked a settlement and licensing pact with Regeneron, paving the way to commercialise its biosimilar product Yesafili in the US.